1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. OSE Immunotherapeutics
  6. News
  7. Sector news
    OSE   FR0012127173

OSE IMMUNOTHERAPEUTICS

(OSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Biotechnology & Medical Research
12:25pModerna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity
MT
09:26aRubius Therapeutics Names Noubar Afeyan Chairman; Shares Rise Pre-Bell
MT
09:15aTRANSCRIPT : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15..
CI
07:44aModerna testing potential monkeypox vaccines
RE
06:41aModerna CEO to Exercise 2013 Option, Donate Funds to Charity
DJ
06:14aANALYST RECOMMENDATIONS : Chubb, Glencore, Metlife, Moonpig, Salesforce...
05:13aGuggenheim Starts IQVIA Holdings at Buy With $244 Price Target
MT
05/23Switzerland's Lonza to Scale Up Inhalation Capabilities at US Site
MT
05/23Seagen Sees Positive Topline Data From Study of Tukysa With Trastuzumab in HER2-Positiv..
MT
05/23What you need to know about the coronavirus right now
RE
05/23Seagen Inc. Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUK..
CI
05/23INSIDER SELL : Moderna
MT
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/18Moderna Seeks Swissmedic Nod For COVID-19 Shot In Children Aged Six Months To Five year..
MT
05/18As COVID cases rise, U.S. health officials mull widening additional booster eligibility
RE
05/18Lonza Opens New Facility for Kodiak Sciences' Retinal Diseases Drug
MT
05/18Moderna, International AIDS Vaccine Initiative to Start Volunteer Screening for Phase 1..
MT
05/18Piper Sandler Adjusts Moderna's Price Target to $214 From $348, Reiterates Overweight R..
MT
05/18From storage to transport, hurdles to getting COVID vaccine to N.Koreans
RE
05/17TRANSCRIPT : Moderna, Inc. - Special Call
CI
05/17FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
DJ
05/16US Stocks Begin Week Mostly Lower Amid Empire State Manufacturing Weakness
MT
05/16US Stocks Begin Week Mostly Lower as First Manufacturing Data for May Turns Negative
MT
05/16Top Midday Gainers
MT
05/16INSIDER SELL : Seagen
MT
05/16Seagen's President, CEO Clay Siegall Resigns Amid Investigation
MT
05/16Seagen Announces Resignation of Clay Siegall as CEO
CI
05/13SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/13Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
MT
05/13Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
MT
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
RE
05/11Moderna completes FDA submission for use of COVID shot in adolescents, kids
RE
05/11Moderna, Inc. Fires Jorge Gomez as CFO
CI
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11Moderna Ousts New Finance Chief Amid Probe at Dentsply
DJ
05/11Moderna Says Recently Named CFO Jorge Gomez Departs; David Meline Continues as CFO
MT
05/11Moderna CFO, Jorge Gomez, Resigns Effective Immediately
MT
05/11Moderna CFO exits a day after taking charge as former employer launches probe
RE
05/11Moderna's new CFO Jorge Gomez steps down
RE
05/10What you need to know about the coronavirus right now
RE
05/10Novavax shares slide 20% on COVID vaccine demand uncertainty
RE
05/09Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates
MT
05/09Novavax 2022 COVID vaccine deliveries off to slow start, shares drop
RE
05/09Novavax posts drop in COVID research funding, slow start to 2022 vaccine delivery
RE
05/09SECTOR UPDATE : Health Care Stocks Declining Ahead of Monday Close
MT
05/09SECTOR UPDATE : Health Care
MT
05/09Seagen's Shares Drop After CEO Clay Siegall Takes Leave of Absence; Roger Dansey Named ..
MT
05/09Top Midday Decliners
MT
05/09Equities Drop Midday as Economic Growth, Inflation Concerns Mount
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on OSE IMMUNOTHERAPEUTICS